Any test to confirm the drugs really induce lupus?

By SWA

 

Yes, certain medications have been known to induce a syndrome that resembles systemic lupus erythematosus (SLE). This condition is referred to as drug-induced lupus erythematosus (DILE). The presentation of DILE is similar to idiopathic SLE but is usually milder and resolves upon discontinuation of the offending drug.

To determine if a patient has DILE rather than idiopathic SLE, the following steps and considerations are typically taken:

  1. History and Medication Review: The most crucial step in diagnosing DILE is a thorough patient history, especially a detailed medication review. Common drugs associated with DILE include:

    • Hydralazine
    • Procainamide
    • Isoniazid
    • Quinidine
    • Anti-TNF medications (like etanercept, infliximab)
    • Certain anticonvulsants
    • Others

    The list of potential drugs is extensive, and newer drugs can also be implicated. The onset of symptoms typically occurs weeks to months after starting the medication.

  2. Laboratory Tests:

    • Antinuclear antibody (ANA) test: Almost all patients with DILE have a positive ANA test.
    • Histone antibodies: The presence of anti-histone antibodies is highly suggestive of DILE, as these are found in a significant percentage of DILE cases (but they can also be found in idiopathic SLE).
    • Other autoantibodies associated with idiopathic SLE, like anti-Sm or anti-dsDNA, are usually absent in DILE.

  3. Symptom Review: Patients with DILE often present with arthralgias, arthritis, and myalgias. Some might have fever or serositis (like pleurisy or pericarditis). However, they usually do not exhibit severe organ damage such as kidney disease, central nervous system involvement, or discoid rash, which are more common in idiopathic SLE.

  4. Resolution upon Discontinuation: One of the hallmark features of DILE is the improvement or resolution of symptoms after stopping the offending drug. Symptoms usually begin to improve within days to weeks after discontinuation and typically resolve completely within several months.

  5. Rechallenge: If there is uncertainty, rechallenging the patient with the suspected drug can induce symptoms again. However, this is generally not done due to the potential risks involved.

  6. Differential Diagnosis: Other conditions that may mimic DILE or SLE need to be considered and ruled out. This includes infections, other rheumatic diseases, and malignancies.

It's essential to differentiate DILE from idiopathic SLE because the management is different. The main treatment for DILE is discontinuing the causative drug, whereas SLE often requires more aggressive and prolonged immunosuppressive therapy.

Always consult with a rheumatologist or appropriate medical specialist when suspecting DILE or SLE in a patient.

Comments

Post a Comment

Popular posts from this blog

Is ME CFS Spinal Muscular Atrophy (SMA)?

By SWA
After a 70-year journey filled with multiple incorrect diagnoses and just as many inappropriate treatments, I finally found an answer to my progressive muscle weakness. Throughout this time, I faced insults and was labeled lazy for my inability to walk long distances or up hills, climb steps, or carry heavy loads. I couldn't ride a bike because sitting on the saddle was impossible. My school grades suffered due to insufficient performance in sports. Instead of receiving comfort from my parents, I was pushed into hard work to strengthen my muscles. Doctors also advised me to exercise my muscles. My life continued with reduced activity, as I had to avoid or quit jobs where standing for extended periods was required or where I couldn't support my skeletal muscle weakness by bracing my elbows. The most excruciatingly painful and weakest period, when I could barely walk, occurred at age 20, during pregnancy. In 2008, an MRI referred by my endocrinologist for permanent adrenal
Read more

Cytokine Storm, Mast Cell Activation Syndrome (MCAS), Endothelial Dysfunction and microclots/thrombosis?

By SWA
Image
Could a virus be the stimulus for cytokine production?   It is well established, but rarely  tested, that a cytokine storm is an overactive immune response characterized by the excessive release of pro-inflammatory cytokines. ( ANA, CRP, and CBC tests are necessary) It can occur in various conditions, such as severe infections (e.g., COVID-19), (and other viruses), autoimmune diseases, and after certain treatments.  Serositis and lymphopenia are common features of systemic lupus erythematosus following SARS-CoV-2 infection: A case report and literature review These cells are called NKG2D+CD8+ T cells and researchers say their aggressive response is responsible for neurological damage suffered from infections beyond just Zika, like COVID-19 and even septic shock. The aggressive response is the result of the body producing large amounts of inflammatory proteins called cytokines, which in moderation help to coordinate the body’s response in battling an infection or injury by
Read more

Strange fibrous clots

By SWA
 AI evaluated: The image shows a table listing various proteins with their corresponding percentages and ranks. These results appear to be from a protein analysis, possibly from a blood sample or a proteomic study. Each row represents a different protein, with the following columns: Protein Name: The name of the protein detected in the sample. Percentage (%): The relative abundance of each protein, indicating its proportion in the sample. Rank (#): The rank of each protein based on its relative abundance. Here is a brief interpretation of some of the listed proteins and their potential significance: Fibrinogen beta chain (35.2848%) and Fibrinogen gamma chain (16.0694%): High levels of fibrinogen proteins suggest a response to injury or inflammation, as fibrinogen is essential for blood clot formation. Hemoglobin subunit beta (14.0401%) and Hemoglobin subunit alpha (2.8530%): Presence of hemoglobin subunits indicates red blood cells or hemolysis in the sample. Actin, cytoplasmic 1
Read more